ERBB2 and carcinoma: Small clusters of CD20+ lymphocytes were identified. The immunophenotype of the carcinoma was triple-negative: tumor cells were negative for estrogen and progesterone receptors as well as for HER2 (score 1+), and the Ki-67 labeling index was 90%. The tumor cells were positive for cytokeratin and SOX10.